Project description
Non-invasive glucose monitoring for diabetics
Diabetes is one of the top 10 causes of death globally. Consistent and accurate monitoring of glucose levels is essential to properly manage diabetes. However, most people diagnosed with diabetes do not monitor their blood sugar as often as they should. In most cases, this is because monitoring is inconvenient and painful. In this context, the EU-funded PREVENTDIABETES project will develop new technology for extracting and analysing blood sugar levels. Specifically, it is inventing a non-invasive technology. The project aims to use the funding from the European Innovation Council (EIC) to further optimise and clinically prove the technology on a wider scale.
Objective
Diabetes is one of the biggest health concerns globally: 6% of the world’s population already lives with diabetes, and another 35% is at a high risk of developing it.
Proper management of diabetes starts with consistent and accurate monitoring of glucose levels. Yet, most diagnosed diabetics do not monitor their blood sugar as often as prescribed, because it is painful and inconvenient to do so. This is clear evidence that the €16+ billion glucose monitors industry needs a change – the current methods are not good enough.
We have invented, patented and productized a new technology category for extracting and analysing blood sugar levels in a completely non-invasive way. We are applying for the EIC blended finance to further miniaturise, optimise, and clinically prove this technology on a wider scale. The financing will turn our break-through scientific discovery into an end user device that can potentially impact over 2 billion people by helping them prevent diabetes onset altogether.
Fields of science
Programme(s)
Funding Scheme
HORIZON-AG - HORIZON Action Grant Budget-BasedCoordinator
00560 HELSINKI
Finland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.